3Dolynchuk KN, Ziesmann M, Serletti JM. Topical putrescine (Fibrostat) in treatmeat of hypertrophic scar phase Ⅱ study.Plast Reconstr Surg, 1999,97:117-123.
4Moulin V, Plamondon M. Differential expression of collagen integrin receptor on fetal vs adult skin fibroblasts: implication in wound contraction during healing. Br J Dermatol, 2002, 147:886-892.
5Chau D, Mancoll JS, Lee S, et al. Tamoxifen down regulates TGF-beta production in keloid fibroblasts. Ann Plast Surg,1998,40:490-493.
6Ward RF, April MM. Mitomycin-c in treatment of tracheal cicatrix after tracheal reconstruction. Pediatr-Otorhinolaryngol,1998,44:221-226.
7Fizpatrick RE. Treatment of inflamed hypertrophic scar using intralesional 5-F. Dermatol Surg, 1999,25 :224-232.?A
8Lim IJ, Phan TT, Tan WTL, et al. Investigation of the influence of keloid derived keratinocytes on fibroblast growth and proliferation in vitro. Plast Reconstr Surg, 2001, 107:797-808.
9Kamath NV, Ormsby A, Bergfeld WF, et al. A light microscopic and immunohistochemical evaluation of scars. J Pathol, 2002,29: 27-32.
10Duncan MR, Harman A, Berman B. Pentoxifylline, pentifylline, and interferous decrease type Ⅰ and Ⅲ procollagen mRNA levels in dermal fibroblasts: evidence for mediation by nuclear factor 1 down-regulation. Invest Dermatol, 1998,104:282-286.
